Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Research
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track Designations to CB-010, an Allogeneic Anti-CD19 CAR-T Cell Therapy
BERKELEY, CA, Nov. 29, 2022 - Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, toda…
News
The Leukemia & Lymphoma Society’s Presence at ASH Showcases Progress to Advance Cures and Care for Blood Cancer Patients
At the 64th Annual American Society of Hematology (ASH) Annual Meeting (December 10-13), The Leukemia & Lymphoma Society (LLS) will be presenting new …
Professional Education Webcasts
Blood Cancer 101: The Basics on Disease, Treatment, and the Role of the HCP
This activity is intended for oncology social workers, psychologists, nurses, and other healthcare professionals involved in the care of patients with…
Professional Education Webcasts
Staying Connected®: Facilitating the Learning Experience During & After Cancer Treatment
This free 6.5 hour online continuing education (CE) course is designed to be completed at a time that is convenient to you – following registration, y…
News
The Leukemia & Lymphoma Society Earns a Four-Star Rating From Charity Navigator
The Leukemia & Lymphoma Society is proud to announce that because of its strong financial health and ongoing accountability and transparency, LLS has …
News
LLS Applauds FDA Approval of New Treatment Option for Pediatric Patients with Hodgkin Lymphoma
The U.S. Food and Drug Administration (FDA) yesterday approved brentuximab vedotin (Adcetris®) in combination with standard dose-intensive chemotherap…
Patient Education Webcasts
Caregiving Over Coffee: Caring & Coping
News
Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood Diseases
The U.S. Food and Drug Administration (FDA) this week approved cobimetinib (Cotellic®), a precision medicine treatment for adults with any of a family…
Patient Education Webcasts
Spotlight On Myeloproliferative Neoplasms (MPNs)
_dam_file_150001.png?crop=true&keep=n&w=400&h=320)
News
FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma
The Food and Drug Administration (FDA) has approved a new treatment, teclistamab (Tecvayli), for adults with multiple myeloma that has returned or con…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
